Orgenesis Market Cap

Orgenesis has a market cap or net worth of $5.45 million as of March 6, 2026. Its market cap has decreased by -41.72% in one year.

Market Cap

5.45M

Enterprise Value

22.52M

Revenue

899.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.56

Market Cap Chart

Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 5.45M, an increase of 2,056.58%. That is a compound annual growth rate of 21.73%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	5.45M	454.99%
Dec 31, 2025	982.83K	-90.00%
Dec 31, 2024	9.83M	-38.42%
Dec 29, 2023	15.96M	-67.96%
Dec 30, 2022	49.81M	-28.75%
Dec 31, 2021	69.91M	-35.68%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BetterLife Pharma	5.83M
Nymox Pharmaceutical	5.17M
Mosaic ImmunoEngineering	5.10M
Synlogic	7.01M
AccuStem Sciences	7.07M
TRON Group	7.38M
Enzon Pharmaceuticals	4.64M
Bioxytran	4.55M

Market Cap Rankings